NASDAQ:KPTI

Karyopharm Therapeutics SEC Filings & 10K Form

$9.71
+0.02 (+0.21 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$9.53
Now: $9.71
$9.95
50-Day Range
$9.69
MA: $11.44
$14.56
52-Week Range
$9.64
Now: $9.71
$25.98
Volume1.40 million shs
Average Volume2.55 million shs
Market Capitalization$728.84 million
P/E RatioN/A
Dividend YieldN/A
Beta0.93

SEC Filings

Karyopharm Therapeutics (NASDAQ:KPTI) SEC Filings

DateFilerForm TypeView
04/07/2021
3:26 PM
Karyopharm Therapeutics (Filer)
Form DEF 14A
03/23/2021
6:50 AM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
6:48 AM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:17 PM
Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:16 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:13 PM
Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:12 PM
Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:10 PM
DEMAREE JOHN (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:09 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:09 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
4:22 PM
Karyopharm Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2021
4:00 PM
Karyopharm Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2021
7:12 PM
Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
7:11 PM
Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
7:10 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
7:09 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
5:49 PM
Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
5:48 PM
Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
5:47 PM
Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
5:46 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
5:45 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
5:44 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
2:12 PM
Consonance Capital Management LP (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/16/2021
1:21 PM
Consonance Capital Management LP (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/12/2021
7:13 AM
Avoro Capital Advisors LLC (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/11/2021
2:09 PM
Karyopharm Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/11/2021
7:19 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/11/2021
6:13 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2021
8:56 PM
Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:34 PM
Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:33 PM
Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:32 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:30 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:28 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
7:06 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
6:39 PM
Karyopharm Therapeutics (Issuer)
Mitchener Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/05/2021
6:33 PM
Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/22/2020
5:16 PM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
10:58 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2020
4:14 PM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
4:17 PM
Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2020
6:05 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2020
3:17 PM
Karyopharm Therapeutics (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2020
3:12 PM
Karyopharm Therapeutics (Issuer)
Schor Chen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/04/2020
7:18 PM
Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
7:16 PM
Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
3:09 PM
Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
3:23 PM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2020
3:11 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/14/2020
5:00 PM
Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
4:56 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
4:54 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2020
8:22 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2020
5:03 PM
Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
4:44 PM
Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/31/2020
3:36 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2020
5:07 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
5:05 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
6:13 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
3:26 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2020
3:24 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2020
6:08 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2020
5:45 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2020
5:43 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
3:07 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
3:05 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
3:34 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2020
3:39 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
3:36 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
3:25 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
3:24 PM
Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
3:22 PM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:36 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:34 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:26 PM
Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:25 PM
Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:22 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2020
4:05 PM
Karyopharm Therapeutics (Filer)
Form 424B5
05/05/2020
6:09 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
3:11 PM
Karyopharm Therapeutics (Filer)
Form DEFA14A
03/17/2020
4:35 PM
Greene Barry E (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
4:30 PM
DEMAREE JOHN (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
4:23 PM
DEMAREE JOHN (Reporting)
Karyopharm Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2020
3:17 PM
Karyopharm Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2020
6:10 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
6:07 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
4:11 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
7:33 PM
Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
5:51 PM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
3:15 PM
Karyopharm Therapeutics (Filer)
Form 424B5
03/02/2020
6:05 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2020
6:39 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/28/2020
7:42 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2020
7:35 AM
Karyopharm Therapeutics (Filer)
Form S-3ASR
02/26/2020
6:17 AM
Karyopharm Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2020
4:58 PM
Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
4:57 PM
Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
4:55 PM
Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
4:54 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
4:53 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.